BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31917968)

  • 1. Clinical and economic burden of community-onset multidrug-resistant infections requiring hospitalization.
    López-Montesinos I; Domínguez-Guasch A; Gómez-Zorrilla S; Duran-Jordà X; Siverio-Parès A; Arenas-Miras MM; Montero MM; Sorli Redó L; Grau S; Horcajada JP
    J Infect; 2020 Mar; 80(3):271-278. PubMed ID: 31917968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The excess financial burden of multidrug resistance in severe gram-negative infections in Singaporean hospitals.
    Ng E; Earnest A; Lye DC; Ling ML; Ding Y; Hsu LY
    Ann Acad Med Singap; 2012 May; 41(5):189-93. PubMed ID: 22760715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia.
    Lee NY; Lee HC; Ko NY; Chang CM; Shih HI; Wu CJ; Ko WC
    Infect Control Hosp Epidemiol; 2007 Jun; 28(6):713-9. PubMed ID: 17520546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors of multidrug-resistant bacterial infections among patients admitted in a tertiary care hospital of north India.
    Vaithiyam V; Ranjan P; Desai D; Mittal A; Kapil A; Wig N; Biswas A
    J Infect Dev Ctries; 2021 Apr; 15(4):544-551. PubMed ID: 33956655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes of hospitalised patients with catheter-associated urinary tract infection in countries with a high rate of multidrug-resistance: the COMBACTE-MAGNET RESCUING study.
    Gomila A; Carratalà J; Eliakim-Raz N; Shaw E; Tebé C; Wolkewitz M; Wiegand I; Grier S; Vank C; Cuperus N; Van den Heuvel L; Vuong C; MacGowan A; Leibovici L; Addy I; Pujol M;
    Antimicrob Resist Infect Control; 2019; 8():198. PubMed ID: 31827779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-hospital costs of community-acquired colonization with multidrug-resistant organisms at a German teaching hospital.
    Engler-Hüsch S; Heister T; Mutters NT; Wolff J; Kaier K
    BMC Health Serv Res; 2018 Sep; 18(1):737. PubMed ID: 30257671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Outcomes and Healthcare Utilization Related to Multidrug-Resistant Gram-Negative Infections in Community Hospitals.
    Dicks KV; Anderson DJ; Baker AW; Sexton DJ; Lewis SS
    Infect Control Hosp Epidemiol; 2017 Jan; 38(1):31-38. PubMed ID: 27724988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation and risk factor profiling of Pseudomonas aeruginosa urinary tract infections: pinpointing those likely to be caused by multidrug-resistant strains.
    Tumbarello M; Raffaelli F; Peghin M; Losito AR; Chirico L; Giuliano G; Spanu T; Sartor A; Fiori B; Bassetti M
    Int J Antimicrob Agents; 2020 Apr; 55(4):105900. PubMed ID: 31931150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Costs Associated with Bloodstream Infections Caused by Multidrug-Resistant Gram-Negative Bacteria Are Due Primarily to Patients with Hospital-Acquired Infections.
    Thaden JT; Li Y; Ruffin F; Maskarinec SA; Hill-Rorie JM; Wanda LC; Reed SD; Fowler VG
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection with multidrug-resistant gram-negative bacteria in a pediatric oncology intensive care unit: risk factors and outcomes.
    Costa Pde O; Atta EH; Silva AR
    J Pediatr (Rio J); 2015; 91(5):435-41. PubMed ID: 26057184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance.
    Micek ST; Wunderink RG; Kollef MH; Chen C; Rello J; Chastre J; Antonelli M; Welte T; Clair B; Ostermann H; Calbo E; Torres A; Menichetti F; Schramm GE; Menon V
    Crit Care; 2015 May; 19(1):219. PubMed ID: 25944081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiologic, clinical, and economic evaluation of an outbreak of clonal multidrug-resistant Acinetobacter baumannii infection in a surgical intensive care unit.
    Young LS; Sabel AL; Price CS
    Infect Control Hosp Epidemiol; 2007 Nov; 28(11):1247-54. PubMed ID: 17926275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of multidrug-resistant bacteria in older hospitalized patients with community-acquired urinary tract infection.
    Madrazo M; Esparcia A; López-Cruz I; Alberola J; Piles L; Viana A; Eiros JM; Artero A
    BMC Infect Dis; 2021 Dec; 21(1):1232. PubMed ID: 34876045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes.
    Tumbarello M; Trecarichi EM; Fiori B; Losito AR; D'Inzeo T; Campana L; Ruggeri A; Di Meco E; Liberto E; Fadda G; Cauda R; Spanu T
    Antimicrob Agents Chemother; 2012 Jun; 56(6):3224-31. PubMed ID: 22450979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia.
    Aliberti S; Di Pasquale M; Zanaboni AM; Cosentini R; Brambilla AM; Seghezzi S; Tarsia P; Mantero M; Blasi F
    Clin Infect Dis; 2012 Feb; 54(4):470-8. PubMed ID: 22109954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors and molecular epidemiology of community-onset, multidrug resistance extended-spectrum β-lactamase-producing
    Park SY; Kang CI; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
    Korean J Intern Med; 2017 Jan; 32(1):146-157. PubMed ID: 27093979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting Multidrug-Resistant Gram-Negative Bacterial Colonization and Associated Infection on Hospital Admission.
    Tseng WP; Chen YC; Yang BJ; Chen SY; Lin JJ; Huang YH; Fu CM; Chang SC; Chen SY
    Infect Control Hosp Epidemiol; 2017 Oct; 38(10):1216-1225. PubMed ID: 28870265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare-Associated Infections Due to Multidrug-Resistant Organisms: a Surveillance Study on Extra Hospital Stay and Direct Costs.
    Giraldi G; Montesano M; Napoli C; Frati P; La Russa R; Santurro A; Scopetti M; Orsi GB
    Curr Pharm Biotechnol; 2019; 20(8):643-652. PubMed ID: 30961489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nosocomial infections due to multidrug-resistant bacteria in cancer patients: a six-year retrospective study of an oncology Center in Western China.
    Jiang AM; Shi X; Liu N; Gao H; Ren MD; Zheng XQ; Fu X; Liang X; Ruan ZP; Yao Y; Tian T
    BMC Infect Dis; 2020 Jun; 20(1):452. PubMed ID: 32600270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug-resistant gram-negative bloodstream infections among residents of long-term care facilities.
    Venkatachalam I; Yang HL; Fisher D; Lye DC; Moi Lin L; Tambyah P; Perl TM
    Infect Control Hosp Epidemiol; 2014 May; 35(5):519-26. PubMed ID: 24709720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.